We are live on ! Find out more
MLAB icon

Mesa Laboratories

161 hedge funds and large institutions have $630M invested in Mesa Laboratories in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 59 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 22

1% more funds holding

Funds holding: 160161 (+1)

2.95% less ownership

Funds ownership: 93.9%90.95% (-2.9%)

10% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 59

28% less capital invested

Capital invested by funds: $878M → $630M (-$248M)

Holders
161
Holders Change
+1
Holders Change %
+0.63%
% of All Funds
2.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
53
Reduced
59
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$4.98M +$38.7K +254 +0.7%
Bank of America
27
Bank of America
North Carolina
$4.33M -$328K -2,155 -6%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$4.12M -$58.1K -381 -1%
Goldman Sachs
29
Goldman Sachs
New York
$3.76M +$2.11M +13,826 +90%
KLC
30
Kent Lake Capital
Nevada
$3.62M
FAM
31
Fred Alger Management
New York
$3.49M -$3.37M -22,081 -45%
Renaissance Technologies
32
Renaissance Technologies
New York
$2.96M +$2.03M +13,300 +137%
Invesco
33
Invesco
Georgia
$2.77M -$31.9M -209,424 -91%
Ohio Public Employees Retirement System (OPERS)
34
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.43M
JP Morgan Chase
35
JP Morgan Chase
New York
$2.29M -$223K -1,462 -8%
RHJA
36
Rice Hall James & Associates
California
$2.19M +$467K +3,062 +22%
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
$2.17M +$2.58M +16,926 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$1.96M +$49.4K +324 +2%
Legal & General Group
39
Legal & General Group
United Kingdom
$1.82M +$251K +1,646 +13%
Luther King Capital Management (LKCM)
40
Luther King Capital Management (LKCM)
Texas
$1.78M
AllianceBernstein
41
AllianceBernstein
Tennessee
$1.72M -$55.2K -362 -3%
Envestnet Asset Management
42
Envestnet Asset Management
Illinois
$1.68M +$12.2K +80 +0.6%
N
43
Nuveen
North Carolina
$1.68M -$944K -6,194 -32%
Select Equity Group
44
Select Equity Group
New York
$1.63M +$1.55M +10,161 +405%
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.49M +$15.2K +100 +0.9%
CS
46
Credit Suisse
Switzerland
$1.34M +$88.5K +581 +6%
CSS
47
Cubist Systematic Strategies
Connecticut
$1.26M +$1.35M +8,829 +872%
Public Sector Pension Investment Board (PSP Investments)
48
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.15M +$12.5K +82 +0.9%
AQR Capital Management
49
AQR Capital Management
Connecticut
$1.05M +$1.24M +8,168 New
MFAM
50
Motley Fool Asset Management
Virginia
$999K +$1.19M +7,777 New

MLAB Hedge Fund Activity: Q2 2023 in Review

161 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2023, worth a combined $630M — down 28% from $878M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MLAB positions and 22 closed out — a net gain of 1 holder — while 53 added to existing stakes and 59 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $6.49M. The largest seller was Invesco, cutting an estimated $31.9M.

  • 161 institutional investors held Mesa Laboratories (MLAB) as of Q2 2023, up from 160 in Q1 2023.
  • Funds reported $630M of Mesa Laboratories stock for Q2 2023, down 28% quarter-over-quarter.
  • 23 funds opened new Mesa Laboratories positions in Q2 2023 and 22 closed out, a net change of +1 holder.
  • The largest Mesa Laboratories buyer in Q2 2023 was Citadel Advisors, an estimated $6.49M added.
  • The largest Mesa Laboratories seller in Q2 2023 was Invesco, an estimated $31.9M sold.

Based on aggregated 13F filings for Q2 2023.